- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: osimertinib
Total 285 results
-
Jiesi Yingda Pharmaceutical Technology (Suzhou)...RecruitingAdvanced Non-small Cell Lung CancerChina
-
Jin Hyoung KangKorea University Anam HospitalNot yet recruitingNon-small Cell Lung CancerKorea, Republic of
-
Peking Union Medical CollegeRecruitingNon-small Cell Lung Cancer | EGFR T790M | Osimertinib | ddPCRChina
-
Karen Reckamp, MD, MSEnviro Therapeutics, Inc.RecruitingLung Cancer | Non Small Cell Lung CancerUnited States
-
TYK Medicines, IncRecruitingNSCLC | EGFR Activating MutationChina
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, Italy, United Kingdom, France, China, Korea, Republic of, Canada, Japan, Netherlands
-
N.N. Blokhin National Medical Research Center of...RecruitingNon Small Cell Lung Cancer | EGFR Gene Mutation | T790MRussian Federation
-
Amsterdam UMC, location VUmcRecruitingNon-Small Cell Lung CancerNetherlands
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingNonsmall-cell Lung CancerChina
-
Goethe UniversityRecruitingNSCLC Stage IV | NSCLC Stage IIIBGermany
-
AstraZenecaRecruitingCarcinoma | Non-Small-Cell LungChina, Israel, Spain, United States, Canada, Italy, Korea, Republic of, Belgium, Bulgaria, Vietnam, Japan, United Kingdom, Brazil, France, Philippines, Taiwan, Thailand, Germany, Poland, Austria, Greece, Turkey, Argentina, Hong Kong, Chile and more
-
Ikena OncologyRecruitingSolid Tumor | Solid Tumors, Adult | Malignant Pleural Mesothelioma (MPM) | Epithelioid Hemangioendothelioma (EHE) | NF2 Deficient Mesothelioma | Other NF2 Deficient Solid Tumors and Solid Tumors With YAP1/TAZ Fusion Genes | NF2 Deficiency | YAP1 or TAZ Gene FusionsUnited States, United Kingdom
-
AstraZenecaRecruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell Carcinoma | Advanced Lung Non-Small Cell... and other conditionsUnited States
-
Shanghai JMT-Bio Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingLocally Advanced or Metastatic Non-Small Cell Lung Cancer | EGFR Exon20 Insertion Mutations
-
Hellenic Cooperative Oncology GroupRecruitingLung Cancer Non-small Cell Stage IVGreece
-
AstraZenecaRecruitingNon-Small Cell Lung CancerUnited States, Spain, China, Italy, Turkey, Argentina, United Kingdom, Canada, Germany, Brazil, Vietnam, Thailand, Poland, Russian Federation, Japan, Korea, Republic of, Taiwan, Malaysia, Singapore, Romania
-
Qingdao Central HospitalRecruiting
-
AIO-Studien-gGmbHAstraZenecaRecruitingNSCLC | EGFR Positive Non-small Cell Lung Cancer | OligoprogressionGermany
-
Wuhan Union Hospital, ChinaNot yet recruitingNon Small Cell Lung Cancer
-
National University Hospital, SingaporeRecruitingNon Small Cell Lung Cancer | EGFR Positive Non-small Cell Lung CancerSingapore
-
Hadassah Medical OrganizationRecruitingNSCLC | Non-small Cell Lung Cancer | EGF-R Positive Non-Small Cell Lung Cancer | Brain Metastases | EGFR Gene MutationIsrael
-
Rennes University HospitalRecruiting
-
Sichuan Baili Pharmaceutical Co., Ltd.RecruitingNon-small Cell Lung CancerChina
-
Hutchison Medipharma LimitedRecruitingNon-small Cell Lung CancerChina
-
Sun Yat-sen UniversityRecruitingNon-Small Cell Lung CancerChina
-
Hutchison Medipharma LimitedRecruitingNon-small Cell Lung CancerChina
-
Guangdong Association of Clinical TrialsNot yet recruiting
-
Qingdao Central HospitalRecruiting
-
Shanghai Chest HospitalJiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruitingLung Cancer | EGFR Gene Mutation
-
Shanghai Chest HospitalNot yet recruiting
-
Merus N.V.RecruitingGastric Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Non-Small Cell Lung Cancer MetastaticUnited States, Spain, France, Italy, Netherlands, Belgium, Korea, Republic of, Germany, Singapore
-
Sun Yat-sen UniversityRecruiting
-
Yonsei UniversityRecruitingNon Small Cell Lung CancerKorea, Republic of
-
Fondazione Ricerca TraslazionaleRecruiting
-
Ohio State University Comprehensive Cancer CenterRecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8United States
-
Instituto Oncológico Dr RosellTurning Point Therapeutics, Inc.Recruiting
-
Shanghai Chest HospitalRecruitingMetastatic Cancer | Adenocarcinoma of Lung | Non-Small Cell Lung Cancer With EGFR Mutation | Locally Advanced Solid TumorChina
-
Beijing Cancer Prevention & Treatment SocietyCancer Institute and Hospital, Chinese Academy of Medical SciencesRecruitingNon Small Cell Lung CancerChina
-
Emory UniversityNational Cancer Institute (NCI)RecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell CarcinomaUnited States
-
Washington University School of MedicineApollomics Inc.RecruitingMetastatic Non Small Cell Lung CancerUnited States
-
The Netherlands Cancer InstituteAstraZenecaRecruitingOsimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed. (OSIRIS)Non-small-cell Lung CarcinomaNetherlands
-
Jacobio Pharmaceuticals Co., Ltd.AbbVieRecruitingNSCLC | Solid TumorUnited States
-
Li Zhang, MDNot yet recruiting
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Taiwan, Japan
-
Guangdong Association of Clinical TrialsRecruiting
-
Shanghai Cancer Hospital, ChinaRecruiting
-
Genprex, Inc.RecruitingCarcinoma, Non-Small Cell LungUnited States
-
Nanjing Medical UniversityNot yet recruitingCardiovascular Disease
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Guardant Health, Inc.RecruitingMetastatic Non-small Cell Lung CancerUnited States